Rezolute, Inc. (RZLT)
4.625
-0.36
(-7.13%)
USD |
NASDAQ |
Aug 28, 16:00
4.65
+0.02
(+0.54%)
After-Hours: 20:00
Rezolute Cash from Operations (Quarterly) : -13.74M for March 31, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -13.74M |
| December 31, 2025 | -20.32M |
| September 30, 2025 | -17.43M |
| June 30, 2025 | -22.00M |
| March 31, 2025 | -17.40M |
| December 31, 2024 | -13.67M |
| September 30, 2024 | -16.01M |
| June 30, 2024 | -18.52M |
| March 31, 2024 | -15.24M |
| December 31, 2023 | -13.02M |
| September 30, 2023 | -10.58M |
| June 30, 2023 | -11.35M |
| March 31, 2023 | -18.05M |
| December 31, 2022 | -7.493M |
| September 30, 2022 | -7.589M |
| June 30, 2022 | -12.11M |
| March 31, 2022 | -13.97M |
| December 31, 2021 | -7.197M |
| September 30, 2021 | -6.341M |
| June 30, 2021 | -5.155M |
| March 31, 2021 | -5.472M |
| December 31, 2020 | -6.263M |
| September 30, 2020 | -3.551M |
| June 30, 2020 | -4.078M |
| March 31, 2020 | -5.679M |
| Date | Value |
|---|---|
| December 31, 2019 | -5.482M |
| September 30, 2019 | -8.929M |
| June 30, 2019 | -3.764M |
| March 31, 2019 | -8.457M |
| December 31, 2018 | -1.651M |
| September 30, 2018 | -1.432M |
| June 30, 2018 | -3.883M |
| March 31, 2018 | -2.178M |
| December 31, 2017 | -3.148M |
| September 30, 2017 | -4.905M |
| June 30, 2017 | -3.644M |
| March 31, 2017 | -3.609M |
| December 31, 2016 | -3.091M |
| September 30, 2016 | -2.968M |
| June 30, 2016 | -3.152M |
| March 31, 2016 | -2.538M |
| December 31, 2015 | -2.285M |
| September 30, 2015 | -2.514M |
| June 30, 2015 | -1.963M |
| March 31, 2015 | -1.908M |
| December 31, 2014 | -1.740M |
| September 30, 2014 | -1.469M |
| June 30, 2014 | -2.098M |
| March 31, 2014 | -0.7076M |
| December 31, 2013 | -0.3653M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -7.588M |
| AbbVie, Inc. | 3.436B |
| Marker Therapeutics, Inc. | -3.716M |
| Avalo Therapeutics, Inc. | -19.99M |
| Krystal Biotech, Inc. | 74.79M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 12.28M |
| Cash from Financing (Quarterly) | 0.747M |
| Free Cash Flow | -73.48M |
| Free Cash Flow Per Share (Quarterly) | -0.132 |
| Free Cash Flow to Equity (Quarterly) | -13.56M |
| Free Cash Flow to Firm (Quarterly) | -13.74M |
| Free Cash Flow Yield | -15.67% |